Technology
Health
Biotechnology

Aldeyra Therapeutics

$5.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.03 (0.53%) Today
-$0.05 (-0.88%) As of 4:49 PM EDT after-hours

Why Robinhood?

You can buy or sell ALDX and other stocks, options, ETFs, and crypto commission-free!

About ALDX

CEO
Employees
19
Headquarters
Founded
2004
Market Cap
153.66M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
449.10K
High Today
$5.78
Low Today
$5.63
Open Price
$5.70
Volume
113.13K
52 Week High
$16.70
52 Week Low
$4.99

Collections

Technology
Health
Biotechnology
Therapy
2014 IPO
US
North America

ALDX News

BenzingaJun 25

No Solace For Aldeyra As Late-Stage Study Of Lead Drug In Anterior Uveitis Fails

170
MarketWatchJun 25

Aldeyra shares slide 29% premarket after trial of eye disease treatment fails to meet goals

209

ALDX Earnings

-$0.52
-$0.46
-$0.39
-$0.33
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market

More ALDX News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.